IVP Antibiotics (Cefazolin, Ceftriaxone, and Cefepime)

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

4 posts / 0 new
Log in or register to post comments
Last post
Thu, 10/01/2020 - 13:44
#1
Michele Holley
Michele Holley's picture
Offline
Last seen: 1 week 5 days ago
Joined: 05/27/2020 - 09:55
IVP Antibiotics (Cefazolin, Ceftriaxone, and Cefepime)

Our organization is looking to move all doses of cefazolin, ceftriaxone, and cefepime to IVP. While this may work from a clinical and financial perspective, I'm concerned about the risks associated with moving from commercially-available products to pharmacy-compounded syringes (risk of error, contamination, expired product management, etc.).

Has any other large hospital or health system moved forward with this conversion and have some "lessons learned" to share with us? Thank you in advance!

Michele
michele.holley@mchs.com

Top